These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 12404286

  • 1. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M.
    Cancer; 2002 Nov 01; 95(9):1923-30. PubMed ID: 12404286
    [Abstract] [Full Text] [Related]

  • 2. [Expression of angiogenic factors and their clinical significances in acute myeloid leukemia].
    Wang Y, Xiao ZJ, Liu P, Peng Z, Han ZC.
    Ai Zheng; 2004 Nov 01; 23(11 Suppl):1423-7. PubMed ID: 15566649
    [Abstract] [Full Text] [Related]

  • 3. Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia.
    Brunner B, Gunsilius E, Schumacher P, Zwierzina H, Gastl G, Stauder R.
    J Hematother Stem Cell Res; 2002 Feb 01; 11(1):119-25. PubMed ID: 11847008
    [Abstract] [Full Text] [Related]

  • 4. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.
    Hu Q, Dey AL, Yang Y, Shen Y, Jilani IB, Estey EH, Kantarjian HM, Giles FJ, Albitar M.
    Cancer; 2004 May 01; 100(9):1884-91. PubMed ID: 15112269
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.
    Cortes J, Kantarjian H, Albitar M, Thomas D, Faderl S, Koller C, Garcia-Manero G, Giles F, Andreeff M, O'Brien S, Keating M, Estey E.
    Cancer; 2003 Mar 01; 97(5):1234-41. PubMed ID: 12599230
    [Abstract] [Full Text] [Related]

  • 6. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [Abstract] [Full Text] [Related]

  • 7. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD, Landman-Parker J, Arcil B, Coudert MC, Gerota I, Benbunan M, Leverger G, Dosquet C.
    Clin Cancer Res; 2001 Mar 01; 7(3):538-43. PubMed ID: 11297245
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
    de Bont ES, Fidler V, Meeuwsen T, Scherpen F, Hählen K, Kamps WA.
    Clin Cancer Res; 2002 Sep 01; 8(9):2856-61. PubMed ID: 12231527
    [Abstract] [Full Text] [Related]

  • 9. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
    Brattström D, Bergqvist M, Larsson A, Holmertz J, Hesselius P, Rosenberg L, Brodin O, Wagenius G.
    Anticancer Res; 1998 Sep 01; 18(2A):1123-7. PubMed ID: 9615776
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G.
    Cancer; 1999 Jan 01; 85(1):178-87. PubMed ID: 9921991
    [Abstract] [Full Text] [Related]

  • 11. [Expression of vascular endothelial growth factor in bone marrow cells of patients with acute myeloid leukemia].
    Xu D, Meng FY, Zhang Y.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr 01; 22(4):357-9. PubMed ID: 12422902
    [Abstract] [Full Text] [Related]

  • 12. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct 01; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

  • 13. The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Hock BD, McKenzie JL, Patton WN, Haring LF, Yang Y, Shen Y, Estey EH, Albitar M.
    Cancer; 2003 Oct 15; 98(8):1681-8. PubMed ID: 14534885
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2001 Oct 15; 12(3):445-52. PubMed ID: 11566625
    [Abstract] [Full Text] [Related]

  • 15. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma.
    Linder C, Linder S, Munck-Wikland E, Strander H.
    Anticancer Res; 1998 Oct 15; 18(3B):2063-8. PubMed ID: 9677468
    [Abstract] [Full Text] [Related]

  • 16. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R.
    Haematologica; 2000 Aug 15; 85(8):800-5. PubMed ID: 10942925
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
    Zhao J, Hu J, Cai J, Yang X, Yang Z.
    Chin Med J (Engl); 2003 May 15; 116(5):772-6. PubMed ID: 12875699
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study.
    Bok RA, Halabi S, Fei DT, Rodriquez CR, Hayes DF, Vogelzang NJ, Kantoff P, Shuman MA, Small EJ.
    Cancer Res; 2001 Mar 15; 61(6):2533-6. PubMed ID: 11289126
    [Abstract] [Full Text] [Related]

  • 19. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M, Ohta Y.
    Cancer; 2003 Sep 15; 98(6):1217-22. PubMed ID: 12973845
    [Abstract] [Full Text] [Related]

  • 20. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A, Robak T, Wrzesień-Kuś A, Krawczyńska A, Lech-Marańda E, Urbańska-Ryś H.
    Eur Cytokine Netw; 2003 Sep 15; 14(3):149-53. PubMed ID: 14656688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.